Abstract
Clot formation is an essential mechanism for wound closure and its principle is ubiquitous in the animal kingdom, comprising invertebrates such as arthropods, echinoderms, and cephalopods as well as all classes of vertebrates (Alsberg and Clark, 1908; Xu and Doolittle, 1990; Feral, 2010). The general principle of coagulation is the conversion of proteins to fibrous material by enzyme reaction in the presence of blood cells. Although the reacting partners (proteins, enzymes, and cell types) strongly differ between the animal groups, the final product always consists mainly or partly of fibrous material. Its functionality seems to rely on the formation of a gauze-like cover sealing the lesion.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Aho HJ, Viljanto J, Raekallio J, and Pelliniemi LJ (1983) Ultrastructural characteristics of cells in human wound collected by Cellstic device. Journal of Surgical Research 35(6): 498–506.
Akassoglou K, Akpinar P, Murray S, and Strickland S (2003) Fibrin is a regulator of Schwann cell migration after sciatic nerve injury in mice. Neuroscience Letters 338(3): 185–188.
Alsberg CL and Clark ED (1908) The blood clot of Limulus polyphemus. Journal of Biological Chemistry 5: 323–329.
Andree C, Voigt M, Wenger A, Erichsen T, Bittner K, Schaefer D, Walgenbach KJ, Borges J, Horch RE, Eriksson E, and Stark GB (2001) Plasmid gene delivery to human keratinocytes through a fibrin-mediated transfection system. Tissue Engineering 7(6): 757–766.
Anglés-Cano E (2006) Plasminogen activation, fibrinolysis, and cell proteolytic activity in antiphospholipid syndrome. In: Khamashta MA (ed) Hughes Syndrome, 2nd Ed. Springer-Verlag, London: pp 457–469.
Bach TL, Barsigian C, Yaen CH, and Martinez J (1998) Endothelial cell VE-cadherin functions as a receptor for the beta15–42 sequence of fibrin. Journal of Biological Chemistry 273(46): 30719–30728.
Bensaid W, Triffitt JT, Blanchat C, Oudina K, Sedel L, and Petite H (2003) A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials 24(14): 2497–2502.
Betz VM, Betz OB, Harris MB, Vrahas MS, and Evans CH (2008) Bone tissue engineering and repair by gene therapy. Frontiers in Bioscience 13: 833–841.
Bleiziffer O, Eriksson E, Yao F, Horch RE, and Kneser U (2007) Gene transfer strategies in tissue engineering. Journal of Cellular and Molecular Medicine 11(2): 206–223.
Blomback B and Okada M (1982) Fibrin gel structure and clotting time. Thrombosis Research 25(1–2): 51–70.
Blomback B, Carlsson K, Hessel B, Liljeborg A, Procyk R, and Aslund N (1989) Native fibrin gel networks observed by 3D microscopy, permeation and turbidity. Biochimica et Biophysica Acta 997(1–2): 96–110.
Boland ED, Wnek GE, Simpson DG, Pawlowski KJ, and Bowlin GL (2001) Tailoring tissue engineering scaffolds using electrostatic processing techniques: a study of poly(glycolic acid). Journal of Macromolecular Science: Pure and Applied Chemistry A 38: 1231–1243.
Boland ED, Matthews JA, Pawlowski KJ, Simpson DG, Wnek GE, and Bowlin GL (2004) Electrospinning collagen and elastin: preliminary vascular tissue engineering. Frontiers in Bioscience 9: 1422–1432.
Bonadio J (2000) Tissue engineering via local gene delivery: update and future prospects for enhancing the technology. Advanced Drug Delivery Reviews 44(2–3): 185–194.
Bonadio J, Smiley E, Patil P, and Goldstein S (1999) Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nature Medicine 5(7): 753–759.
Borges J, Torio-Padron N, Momeni A, Mueller MC, Tegtmeier FT, and Stark BG (2006) Adipose precursor cells (preadipocytes) induce formation of new vessels in fibrin glue on the newly developed cylinder chorioallantoic membrane model (CAM). Minimally Invasive Therapy & Allied Technologies 15(4): 246–252.
Branski LK, Masters OE, Herndon DN, Mittermayr R, Redl H, Traber DL, Cox RA, Kita K, and Jeschke MG (2010) Pre-clinical evaluation of liposomal gene transfer to improve dermal and epidermal regeneration. Gene Therapy 17(6): 770–778.
Brown LF, Lanir N, McDonagh J, Tognazzi K, Dvorak AM, and Dvorak HF (1993) Fibroblast migration in fibrin gel matrices. American Journal of Pathology 142(1): 273–283.
Buchta C, Hedrich HC, Macher M, Hocker P, and Redl H (2005) Biochemical characterization of autologous fibrin sealants produced by CryoSeal and Vivostat in comparison to the homologous fibrin sealant product Tissucol/Tisseel. Biomaterials 26(31): 6233–6241.
Cao Y, Sun Z, Liao L, Meng Y, Han Q, and Zhao RC (2005) Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochemical and Biophysical Research Communications 332(2): 370–379.
Catelas I, Sese N, Wu BM, Dunn JC, Helgerson S, and Tawil B (2006) Human mesenchymal stem cell proliferation and osteogenic differentiation in fibrin gels in vitro. Tissue Engineering 12(8): 2385–2396.
Chang MC, Wang BR, and Huang TF (1995) Characterization of endothelial cell differential attachment to fibrin and fibrinogen and its inhibition by Arg-Gly-Asp-containing peptides. Journal of Thrombosis and Haemostasis 74(2): 764–769.
Chernysh IN and Weisel JW (2008) Dynamic imaging of fibrin network formation correlated with other measures of polymerization. Blood 111(10): 4854–4861.
Christman KL, Fang Q, Yee MS, Johnson KR, Sievers RE, and Lee RJ (2005) Enhanced neovasculature formation in ischemic myocardium following delivery of pleiotrophin plasmid in a biopolymer. Biomaterials 26(10): 1139–1144.
Ciano PS, Colvin RB, Dvorak AM, McDonagh J, and Dvorak HF (1986) Macrophage migration in fibrin gel matrices. Laboratory Investigation 54(1): 62–70.
Collet JP, Park D, Lesty C, Soria J, Soria C, Montalescot G, and Weisel JW (2000) Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy. Arteriosclerosis, Thrombosis, and Vascular Biology 20(5): 1354–1361.
Collet JP, Nagaswami C, Farrell DH, Montalescot G, and Weisel JW (2004) Influence of gamma’ fibrinogen splice variant on fibrin physical properties and fibrinolysis rate. Arteriosclerosis, Thrombosis, and Vascular Biology 24(2): 382–386.
Cooper AV, Standeven KF, and Ariens RA (2003) Fibrinogen gamma-chain splice variant gamma’ alters fibrin formation and structure. Blood 102(2): 535–540.
Corbett SA and Schwarzbauer JE (1999) Requirements for alpha(5)beta(1) integrin-mediated retraction of fibronectin-fibrin matrices. Journal of Biological Chemistry 274(30): 20943–20948.
Cox S, Cole M, and Tawil B (2004) Behavior of human dermal fibroblasts in three-dimensional fibrin clots: dependence on fibrinogen and thrombin concentration. Tissue Engineering 10(5–6): 942–954.
De Cristofaro R and De Candia E (2003) Thrombin domains: structure, function and interaction with platelet receptors. Journal of Thrombosis and Thrombolysis 15(3): 151–163.
de Maat MP and Verschuur M (2005) Fibrinogen heterogeneity: inherited and noninherited. Current Opinion in Hematology 12(5): 377–383.
des Rieux A, Shikanov A, and Shea LD (2009) Fibrin hydrogels for non-viral vector delivery in vitro. Journal of Controlled Release 136(2): 148–154.
Di Stasio E, Nagaswami C, Weisel JW, and Di Cera E (1998) Clregulates the structure of the fibrin clot. Biophysical Journal 75(4): 1973–1979.
Doolittle RF, Spraggon G, and Everse SJ (1997) Evolution of vertebrate fibrin formation and the process of its dissolution. Ciba Foundation Symposium 212: 4–17.
Farrell DH and al Mondhiry HA (1997) Human fibroblast adhesion to fibrinogen. Biochemistry 36(5): 1123–1128.
Feral JP (2010) Wound healing after arm amputation in Sepia officinalis (Cephalopoda: Sepioidea). Journal of Invertebrate Pathology 52: 380–388.
Ferry JD and Morrison PR (1947) Preparation and properties of serum and plasma proteins; the conversion of human fibrinogen to fibrin under various conditions. Journal of the American Chemical Society 69(2): 388–400.
Formhals A (1934): Progress and apparatus for preparing artificial threads. USA Patent No. US 1,975,504.
Fürst W, Banerjee A, and Redl H (2007) Comparison of structure, strength and cytocompatibility of a fibrin matrix supplemented either with tranexamic acid or aprotinin. Journal of Biomedical Materials Research Part B: Applied Biomaterials 82(1): 109–114.
Gabriel DA, Muga K, and Boothroyd EM (1992) The effect of fibrin structure on fibrinolysis. Journal of Biological Chemistry 267(34): 24259–24263.
Gailit J, Clarke C, Newman D, Tonnesen MG, Mosesson MW, and Clark RA (1997) Human fibroblasts bind directly to fibrinogen at RGD sites through integrin alpha(v)beta3. Experimental Cell Research 232(1): 118–126.
Gandossi E, Lunven C, and Berry CN (2000) Role of clot-associated (-derived) thrombin in cell proliferation induced by fibrin clots in vitro. British Journal of Pharmacology 129(5): 1021–1027.
Garcia AJ, Vega MD, and Boettiger D (1999) Modulation of cell proliferation and differentiation through substrate-dependent changes in fibronectin conformation. Molecular Biology of the Cell 10(3): 785–798.
Gille J, Meisner U, Ehlers EM, Muller A, Russlies M, and Behrens P (2005) Migration pattern, morphology and viability of cells suspended in or sealed with fibrin glue: a histomorphologic study. Tissue and Cell 37(5): 339–348.
Gimble JM, Katz AJ, and Bunnell BA (2007) Adipose-derived stem cells for regenerative medicine. Circulation Research 100(9): 1249–1260.
Goessl A and Redl H (2005) Optimized thrombin dilution protocol for a slowly setting fibrin sealant in surgery. European Surgery 37(1): 43–51.
Gorodetsky R, Vexler A, An J, Mou X, and Marx G (1998) Haptotactic and growth stimulatory effects of fibrin(ogen) and thrombin on cultured fibroblasts. Journal of Laboratory and Clinical Medicine 131(3): 269–280.
Gralnick HR, Givelber H, and Abrams E (1978) Dysfibrinogenemia associated with hepatoma. Increased carbohydrate content of the fibrinogen molecule. New England Journal of Medicine 299(5): 221–226.
Greiling D and Clark RA (1997) Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix. Journal of Cell Science 110(Pt 7): 861–870.
Guo M, Toda K, and Grinnell F (1990) Activation of human keratinocyte migration on type I collagen and fibronectin. Journal of Cell Science 96(Pt 2): 197–205.
Halvorsen YD, Franklin D, Bond AL, Hitt DC, Auchter C, Boskey AL, Paschalis EP, Wilkison WO, and Gimble JM (2001) Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells. Tissue Engineering 7(6): 729–741.
Harlow E and Lane D (1988) Antibodies: A Laboratory Manual, 1st Ed. Cold Spring Harbor Laboratory Publications Press, New York.
Hausman GJ and Richardson RL (2004) Adipose tissue angiogenesis. Journal of Animal Science 82(3): 925–934.
Hiraoka N, Allen E, Apel IJ, Gyetko MR, and Weiss SJ (1998) Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 95(3): 365–377.
Ho W, Tawil B, Dunn JC, and Wu BM (2006) The behavior of human mesenchymal stem cells in 3D fibrin clots: dependence on fibrinogen concentration and clot structure. Tissue Engineering 12(6): 1587–1595.
Hotary KB, Yana I, Sabeh F, Li XY, Holmbeck K, Birkedal-Hansen H, Allen ED, Hiraoka N, and Weiss SJ (2002) Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and-independent processes. Journal of Experimental Medicine 195(3): 295–308.
Jiang Y, Ding G, and Lu S (2010) Behavior of dermal fibroblasts on microdot arrays yields insight into wound healing mechanisms. Molecular Biology Reports (in press).
Kaibara M (1973) Dynamic viscoelastic study of the formation of fibrin networks in fibrinogen-thrombin systems and plasma. Biorheology 10(1): 61–73.
Kaijzel EL, Koolwijk P, van Erck MG, van Hinsbergh VW, and de Maat MP (2006) Molecular weight fibrinogen variants determine angiogenesis rate in a fibrin matrix in vitro and in vivo. Journal of Thrombosis and Haemostasis 4(9): 1975–1981.
Kaminski M and McDonagh J (1983) Studies on the mechanism of thrombin. Interaction with fibrin. Journal of Biological Chemistry 258(17): 10530–10535.
Katti DS, Robinson KW, Ko FK, and Laurencin CT (2004) Bioresorbable nanofiber-based systems for wound healing and drug delivery: optimization of fabrication parameters. Journal of Biomedical Materials Research Part B: Applied Biomaterials 70(2): 286–296.
Kim JP, Zhang K, Chen JD, Kramer RH, and Woodley DT (1994) Vitronectin-driven human keratinocyte locomotion is mediated by the alpha v beta 5 integrin receptor. Journal of Biological Chemistry 269(43): 26926–26932.
Kim JP, Zhang K, Chen JD, Wynn KC, Kramer RH, and Woodley DT (1992) Mechanism of human keratinocyte migration on fibronectin: unique roles of RGD site and integrins. Journal of Cellular Physiology 151(3): 443–450.
Kita R, Takahashi A, Kaibara M, and Kubota K (2002) Formation of fibrin gel in fibrinogen-thrombin system: static and dynamic light scattering study. Biomacromolecules 3(5): 1013–1020.
Knox P, Crooks S, and Rimmer CS (1986) Role of fibronectin in the migration of fibroblasts into plasma clots. Journal of Cell Biology 102(6): 2318–2323.
Kral JG and Crandall DL (1999) Development of a human adipocyte synthetic polymer scaffold. Plastic and Reconstructive Surgery 104(6): 1732–1738.
Kubo M, Van de Water L, Plantefaber LC, Mosesson MW, Simon M, Tonnesen MG, Taichman L, and Clark RA (2001) Fibrinogen and fibrin are anti-adhesive for keratinocytes: a mechanism for fibrin eschar slough during wound repair. Journal of Investigative Dermatology 117(6): 1369–1381.
Langer R and Vacanti JP (1993) Tissue engineering. Science 260(5110): 920–926.
Lanir N Cia PS Van de WL McDonagh J Dvorak AM and Dvorak HF 1988 Macrophage migration in fibrin gel matrices. II. Effects of clotting factor XIII fibronectin and glycosamiglycan content on cell migration. Journal of Immulogy 1407 2340–2349.
Laurens N, Koolwijk P, and de Maat MP (2006) Fibrin structure and wound healing. Journal of Thrombosis and Haemostasis 4(5): 932–939.
Lei P, Padmashali RM, and Andreadis ST (2009) Cell-controlled and spatially arrayed gene delivery from fibrin hydrogels. Biomaterials 30(22): 3790–3799.
Lim BC, Ariens RA, Carter AM, Weisel JW, and Grant PJ (2003) Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk. The Lancet 361(9367): 1424–1431.
Lin F, Ren XD, Doris G, and Clark RA (2005) Three-dimensional migration of human adult dermal fibroblasts from collagen lattices into fibrin/fibronectin gels requires syndecan-4 proteoglycan. Journal of Investigative Dermatology 124(5): 906–913.
Liu CY, Nossel HL, and Kaplan KL (1979) The binding of thrombin by fibrin. Journal of Biological Chemistry 254(20): 10421–10425.
Locksley RM, Killeen N, and Lenardo MJ (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104(4): 487–501.
Lyon ME, Fine JS, Henderson PJ, and Lyon AW (1995) D-phenylalanyl-L-prolyl-L-arginine chloromethyl ketone (PPACK): alternative anticoagulant to heparin salts for blood gas and electrolyte specimens. Clinical Chemistry 41(7): 1038–1041.
Macasev DJ, DiOrio JP, Gugerell A, Goppelt A, Gulle H, and Bittner M (2010) Cell compatibility of fibrin sealants: in vitro study with cells involved in soft tissue engineering. Journal of Biomaterials Applications (in press).
MacPhee MJ, Singh MP, Brady R, Akhyani N, Liau G, Lasa C, Hue C, Best A, and Drohan W (1996) Fibrin sealant: a versatile delivery vehicle for drugs and biologics. In: Sierra DH and Saltz R (eds) Surgical Adhesives and Sealants: Current Technology and Applications. Technomic Publishing AG, Basel: pp 109–120.
Maghzal GJ, Brennan SO, and George PM (2005) The sialic acid content of fibrinogen decreases during pregnancy and increases in response to fibrate therapy. Thrombosis Research 115(4): 293–299.
Mann BK (2003) Biologic gels in tissue engineering. Clinics in Plastic Surgery 30(4): 601–609.
Martin P (1997) Wound healing — aiming for perfect skin regeneration. Science 276: 75–81.
Martinowitz U and Saltz R (1996) Fibrin sealant. Current Opinion in Hematology 3(5): 395–402.
Michlits W, Mittermayr R, Schafer R, Redl H, and Aharinejad S (2007) Fibrin-embedded administration of VEGF plasmid enhances skin flap survival. Wound Repair and Regeneration 15(3): 360–367.
Midwood KS, Mao Y, Hsia HC, Valenick LV, and Schwarzbauer JE (2006) Modulation of cell-fibronectin matrix interactions during tissue repair. Journal of Investigative Dermatology Symposium Proceedings 11(1): 73–78.
Miranville A, Heeschen C, Sengenes C, Curat CA, Busse R, and Bouloumie A (2004) Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation 110(3): 349–355.
Mooney R, Tawil B, and Mahoney M (2010) Specific fibrinogen and thrombin concentrations promote neuronal rather than glial growth when primary neural cells are seeded within plasma-derived fibrin gels. Tissue Engineering: Parts A 16(5): 1607–1619.
Morton TJ, Furst W, van Griensven M, and Redl H (2009) Controlled release of substances bound to fibrin-anchors or of DNA. Drug Delivery 16(2): 102–107.
Morton TJ, Nikkola L, Grasl C, Wolbank S, Moritz M, Pfeifer S, Redl H, and van Griensven M (2010) Electrospun fibrin nanofibers for the use in tissue engineering. (unpublished).
Mosesson MW, DiOrio JP, Hernandez I, Hainfeld JF, Wall JS, and Grieninger G (2004) The ultrastructure of fibrinogen-420 and the fibrin-420 clot. Biophysical Chemistry 112(2–3): 209–214.
Mosher DF and Johnson RB (1983) Specificity of fibronectin — fibrin cross-linking. Annals of the New York Academy of Sciences 408: 583–594.
Nair CH, Shah GA, and Dhall DP (1986) Effect of temperature, pH and ionic strength and composition on fibrin network structure and its development. Thrombosis Research 42(6): 809–816.
Naito M, Nomura H, and Iguchi A (1996) Migration of cultured vascular smooth muscle cells into non-crosslinked fibrin gels. Thrombosis Research 84(2): 129–136.
O’Toole EA (2001) Extracellular matrix and keratinocyte migration. Clinical and Experimental Dermatology 26(6): 525–530.
Pankajakshan D and Krishnan LK (2009) Design of fibrin matrix composition to enhance endothelial cell growth and extracellular matrix deposition for in vitro tissue engineering. Artificial Organs 33(1): 16–25.
Peterbauer-Scherb A, Danzer M, Gabriel C, van Griensven M, Redl H, and Wolbank S (2010) In vitro adipogenesis of adipose-derived stem cells in 3D fibrin matrix of low component concentration. Journal of Tissue Engineering and Regenerative Medicine (submitted).
Planat-Benard V, Silvestre JS, Cousin B, Andre M, Nibbelink M, Tamarat R, Clergue M, Manneville C, Saillan-Barreau C, Duriez M, Tedgui A, Levy B, Penicaud L, and Casteilla L (2004) Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 109(5): 656–663.
Redl H, Schlag G, and Dinges HP (1985) Vergleich zweier Fibrinkleber. Medizinische Welt 36: 769–776.
Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, Pell CL, Johnstone BH, Considine RV, and March KL (2004) Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109(10): 1292–1298.
Richardson TP, Murphy WL, and Mooney DJ (2001) Polymeric delivery of proteins and plasmid DNA for tissue engineering and gene therapy. Critical Reviews™ in Eukaryotic Gene Expression 11(1–3): 47–58.
Ronfard V and Barrandon Y (2001) Migration of keratinocytes through tunnels of digested fibrin. Proceedings of the National Academy of Sciences USA 98(8): 4504–4509.
Safford KM, Hicok KC, Safford SD, Halvorsen YD, Wilkison WO, Gimble JM, and Rice HE (2002) Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochemical and Biophysical Research Communications 294(2): 371–379.
Sahni A and Francis CW (2000) Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood 96(12): 3772–3778.
Sahni A, Odrljin T, and Francis CW (1998) Binding of basic fibro-blast growth factor to fibrinogen and fibrin. Journal of Biological Chemistry 273(13): 7554–7559.
Sahni A, Guo M, Sahni SK, and Francis CW (2004) Interleukin-1beta but not IL-1alpha binds to fibrinogen and fibrin and has enhanced activity in the bound form. Blood 104(2): 409–414.
Schense JC and Hubbell JA (1999) Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa. Bioconjugate Chemistry 10(1): 75–81.
Schillinger U, Wexel G, Hacker C, Kullmer M, Koch C, Gerg M, Vogt S, Ueblacker P, Tischer T, Hensler D, Wilisch J, Aigner J, Walch A, Stemberger A, and Plank C (2008) A fibrin glue composition as carrier for nucleic acid vectors. Pharmaceutical Research 25(12): 2946–2962.
Schlag G and Redl H (1986) Fibrin Sealant in Operative Medicine. Springer-Verlag, Berlin.
Schmoekel HG, Weber FE, Seiler G, von Rechenberg B, Schense JC, Schawalder P, and Hubbell J (2004) Treatment of nonunions with nonglycosylated recombinant human bone morphogenetic protein-2 delivered from a fibrin matrix. Veterinary Surgery 33(2): 112–118.
Schmoekel HG, Weber FE, Schense JC, Gratz KW, Schawalder P, and Hubbell JA (2005) Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices. Biotechnology and Bioengineering 89(3): 253–262.
Seo MJ, Suh SY, Bae YC, and Jung JS (2005) Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. Biochemical and Biophysical 328(1): 258–264.
Smadja DM, Basire A, Amelot A, Conte A, Bieche I, Le Bonniec BF, Aiach M, and Gaussem P (2008) Thrombin bound to a fibrin clot confers angiogenic and haemostatic properties on endothelial progenitor cells. Journal of Cellular and Molecular Medicine 12(3): 975–986.
Spotnitz WD (2001) Commercial fibrin sealants in surgical care. American Journal of Surgery 182(Suppl 2): 8S–14S.
Tanzi MC and Fare S (2009) Adipose tissue engineering: state of the art, recent advances and innovative approaches. Expert Review of Medical Devices 6(5): 533–551.
Trentin D, Hubbell J, and Hall H (2005) Non-viral gene delivery for local and controlled DNA release. Journal of Controlled Release 102(1): 263–275.
van Hinsbergh VW, Collen A, and Koolwijk P (2001) Role of fibrin matrix in angiogenesis. Annals of the New York Academy of Sciences 936: 426–437.
Veklich Y, Francis CW, White J, and Weisel JW (1998) Structural studies of fibrinolysis by electron microscopy. Blood 92(12): 4721–4729.
Vlodavsky I, Bar-Shavit R, Ishai-Michaeli R, Bashkin P, and Fuks Z (1991) Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism? Trends in Biochemical Sciences 16(7): 268–271.
von Heimburg D, Hemmrich K, Zachariah S, Staiger H, and Pallua N (2005) Oxygen consumption in undifferentiated versus differentiated adipogenic mesenchymal precursor cells. Respiratory Physiology & Neurobiology 146(2–3): 107–116.
Wagoner B, Hausman DB, and Harris RB (2006) Direct and indirect effects of leptin on preadipocyte proliferation and differentiation. American Journal of Physiology — Regulatory, Integrative and Comparative Physiology 290(6): R1557–R1564.
Weisel JW and Nagaswami C (1992) Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled. Biophysical Journal 63(1): 111–128.
Weisel JW, Veklich Y, and Gorkun O (1993) The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots. Journal of Molecular Biology 232(1): 285–297.
Wnek GE, Carr ME, Simpson DG, and Bowlin GL (2003) Electrospinning of nanofiber fibrinogen structures. Nano Letters 3: 213–216.
Wolberg AS, Monroe DM, Roberts HR, and Hoffman M (2003) Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk. Blood 101(8): 3008–3013.
Wong C, Inman E, Spaethe R, and Helgerson S (2003) Fibrinbased biomaterials to deliver human growth factors. Journal of Thrombosis and Haemostasis 89(3): 573–582.
Xu X and Doolittle RF (1990) Presence of a vertebrate fibrinogen-like sequence in an echinoderm. Proceedings of the National Academy of Sciences USA 87(6): 2097–2101.
Zhao H, Ma L, Zhou J, Mao Z, Gao C, and Shen J (2008) Fabrication and physical and biological properties of fibrin gel derived from human plasma. Journal of Biomedical Materials 3(1): 015001.
Zheng DN, Li QF, Lei H, Zheng SW, Xie YZ, Xu QH, Yun X, and Pu LL (2008) Autologous fat grafting to the breast for cosmetic enhancement: experience in 66 patients with long-term follow up. Journal of Plastic, Reconstructive & Aesthetic Surgery 61(7): 792–798.
Zisch AH, Schenk U, Schense JC, Sakiyama-Elbert SE, and Hubbell JA (2001) Covalently conjugated VEGF — fibrin matrices for endothelialization. Journal of Controlled Release 72(1–3): 101–113.
Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, and Hedrick MH (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Engineering 7(2): 211–228.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag/Wien
About this chapter
Cite this chapter
Nürnberger, S. et al. (2010). Properties and Potential Alternative Applications of Fibrin Glue. In: von Byern, J., Grunwald, I. (eds) Biological Adhesive Systems. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0286-2_16
Download citation
DOI: https://doi.org/10.1007/978-3-7091-0286-2_16
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-0141-4
Online ISBN: 978-3-7091-0286-2
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)